Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Dec 3, 2010

Premium

Aushon Biosystems has appointed Sven Beushausen to be its new chief scientific officer. He joins the Billerica, Mass.-based protein array technologies firm from Pfizer, where he was molecular medicine site leader.

Beushausen also has held other senior scientific positions within Pfizer, and previously worked as director of manufacturing technologies for Invitrogen (now Life Technologies).


Caris Life Sciences announced last week several recent additions and appointments to its senior scientific staff at its facilities in Lausanne, Switzerland, and Phoenix, Ariz.

Andy Tasinato was named director of research at the company's new R&D lab in Lausanne. Previously he was head of research at the University Hospital Lausanne and Bern. He will be overseeing Elodie Ristorcelli, who received her doctorate in biochemistry at the Faculty of Medicine in Marseille; and Gherici Hassaine, previously head of BioXtal's R&D laboratory.

Dan Holterman joined the company's Phoenix facility as a senior research scientist along with scientists Wang-Juh Chen, Jorge Schettini, and Tassilo Hornung.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.